GALTGalectin Therapeutics Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 15819
Ticker: GALT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2002-09-04
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GALT

Detail

Enriched 2026-08-14 20:47

Market cap: $316,667,882.16
Shares outstanding (class): 65,856,898
Shares outstanding (weighted): 100,849,644
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 9
Location: NORCROSS, GA
Homepage: https://www.galectintherapeutics.com
Description: Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Market cap and share counts drift.

Funds holding this security

11 funds · 11 positions · $6.05M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$3.77M	0.00%	1,351,443 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.57M	0.00%	563,630 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$319.3K	0.03%	114,442 NS	FIGI
Horizon Kinetics Medical ETF Listed Funds Trust	MEDX	$137.3K	0.76%	49,226 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$75.1K	0.00%	26,902 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$68.5K	0.00%	24,567 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$63.8K	0.00%	22,865 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$23.9K	0.01%	8,571 NS	FIGI
Small Cap Core Fund Northern Funds	—	$15.0K	0.00%	5,380 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$3.1K	0.00%	1,100 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$3.0K	0.00%	1,086 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGALT
FIGI_COMPOSITEBBG000BK6FP5
FIGI_SHARE_CLASSBBG001S9NYW2
CIK0001133416
ISINUS3632252025
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Galectin Therapeutics is a biopharmaceutical company developing therapies, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.